These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 17424919

  • 21. [The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients after surgery].
    Czygier M, Ławicki S, Szmitkowski M.
    Przegl Lek; 2009; 66(8):433-6. PubMed ID: 20043590
    [Abstract] [Full Text] [Related]

  • 22. [Selected hematopoietic cytokines in patients with colorectal cancer].
    Mroczko B, Ławicki S, Szmitkowski M, Czygier M, Okulczyk B, Piotrowski Z.
    Pol Merkur Lekarski; 2003 Nov; 15(89):416-9. PubMed ID: 14969133
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S, Będkowska GE, Szmitkowski M.
    Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
    [Abstract] [Full Text] [Related]

  • 25. [Plasma macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor levels in continuous ambulatory peritoneal dialysis patients].
    Saionji K, Hamada T, Higurashi H, Shimizu T, Hukuromoto T, Takeshima S, Kurotani W.
    Rinsho Byori; 1997 May; 45(5):493-7. PubMed ID: 9170979
    [Abstract] [Full Text] [Related]

  • 26. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 27. [Granulocyte colony stimulating factor (G-CSF) in diagnosis and monitoring of non-small-cell lung cancer (NSCLC)].
    Mroczko B, Szmitkowski M, Czygier M.
    Pol Arch Med Wewn; 2000 May 01; 103(3-4):163-8. PubMed ID: 11236243
    [Abstract] [Full Text] [Related]

  • 28. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G, Malamou-Mitsi V, Briasoulis E, Damala K, Vassou A, Vartholomatos G, Kolaitis N, Pavlidis N.
    Cancer; 2004 Oct 15; 101(8):1767-75. PubMed ID: 15386335
    [Abstract] [Full Text] [Related]

  • 29. [The plasma level of sL-selectin, myeloperoxidase and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients in the course of chemotherapy].
    Czygier M, Ławicki S, Uścinowicz A, Szmitkowski M.
    Przegl Lek; 2008 Oct 15; 65(3):115-8. PubMed ID: 18624117
    [Abstract] [Full Text] [Related]

  • 30. Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients.
    Lawicki S, Gacuta-Szumarska E, Będkowska GE, Szmitkowski M.
    Growth Factors; 2012 Dec 15; 30(6):357-66. PubMed ID: 22988839
    [Abstract] [Full Text] [Related]

  • 31. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.
    Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC.
    J Clin Oncol; 2004 Oct 15; 22(20):4059-66. PubMed ID: 15381683
    [Abstract] [Full Text] [Related]

  • 32. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E, Ławicki S.
    BMC Cancer; 2019 Apr 29; 19(1):398. PubMed ID: 31035945
    [Abstract] [Full Text] [Related]

  • 33. Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
    Zajkowska M, Zbucka-Krętowska M, Sidorkiewicz I, Lubowicka E, Gacuta E, Szmitkowski M, Chrostek L, Ławicki S.
    Tumour Biol; 2018 Jul 29; 40(7):1010428318790363. PubMed ID: 30052166
    [Abstract] [Full Text] [Related]

  • 34. Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation.
    Denizot Y, Karoutsos S, Nathan N.
    Cytokine; 2001 Mar 07; 13(5):314-6. PubMed ID: 11243710
    [Abstract] [Full Text] [Related]

  • 35. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
    Mroczko B, Szmitkowski M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B.
    Int J Colorectal Dis; 2007 Jan 07; 22(1):33-8. PubMed ID: 16520929
    [Abstract] [Full Text] [Related]

  • 36. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients.
    Bordbar E, Malekzadeh M, Ardekani MT, Doroudchi M, Ghaderi A.
    Asian Pac J Cancer Prev; 2012 Jan 07; 13(10):5307-12. PubMed ID: 23244154
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Granulocyte-colony stimulating factor (G-CSF) in the plasma and activity of enzymes in granulocytes of breast cancer patients].
    Czygier M, Ławicki S, Szmitkowski M, Mroczko B, Omyła J.
    Ginekol Pol; 2004 Feb 07; 75(2):99-104. PubMed ID: 15108580
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.